cimetidine has been researched along with kb 5492 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morimoto, Y; Oshima, S; Shimohara, K; Sukamoto, T | 1 |
| Hara, H; Morimoto, Y; Shimohara, K; Sukamoto, T; Tanaka, K | 1 |
2 other study(ies) available for cimetidine and kb 5492
| Article | Year |
|---|---|
Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cimetidine; Diterpenes; Gastric Acid; Gastric Mucosa; Hexosamines; Male; Piperazines; Rats; Rats, Inbred Strains; Stomach Ulcer | 1991 |
4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from t
Topics: Animals; Anti-Ulcer Agents; Bicarbonates; Cimetidine; Cysteamine; Duodenal Ulcer; Duodenum; Gastric Acid; Intestinal Secretions; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, sigma | 1994 |